The Biomet M2a Magnum System is a metal-on-metal device used for primary and revision hip replacement. The device was approved by the U.S. Food and Drug Administration (FDA) through the 510(k) process on October 1, 2004.
Medical literature has suggested that Biomet’s M2a Magnum implant is similar in design to DePuy’s recalled ASR hip implant. While the Biomet M2a Magnum has not been recalled, patients reported complications similar to those seen with other defective metal-on-metal hip replacements including: swelling of the hip and groin, bone staining, nerve, muscle and tissue damage, hip, groin and leg pain and elevated metal ion levels in the bloodstream.
There is ongoing litigation regarding the defective Biomet M2a Magnum device. If you underwent hip replacement surgery with the Biomet M2a Magnum Metal-on-Metal Hip, please contact our firm at 1-800-247-1623 or email@example.com for a free consultation to discuss your legal rights.
Click here for frequently asked questions regarding Biomet’s M2a Magnum implant.
M2a Magnum™ is a trademark of Biomet Manufacturing Corp. and is used for informational and product identification purposes only.